ADVERTISEMENT

John N. Evans, DPM, FACFAS, DABFAS

Videos

More on Innovations and Emerging Thinking in PAD

01/25/2023

John N. Evans , DPM, FACFAS, DABFAS;

Dr. Evans shares more about the trajectory of technology and thinking when it comes to PAD, including what clinicians can do to improve outcomes.

Dr. Evans shares more about the trajectory of technology and thinking when it comes to PAD, including what clinicians can do to improve outcomes.

Dr. Evans shares more about the...

01/25/2023

Podiatry Today

Practical Insights On Current And Emerging Options For PAD Assessment

Wound Care Q&A

Practical Insights On Current And Emerging Options For PAD Assessment

04/26/2021

John N. Evans , DPM, FACFAS, DABFAS;

Adriana Strimbu , DPM;

Kazu Suzuki , DPM, CWS;

Raymond Abdo , DPM, CWS;

Peripheral arterial disease can present in a multitude of ways in podiatric practice. How are physicians best able to assess and formulate treatment plans for these patients? Here the panelists share their experience with diagnostic...

Peripheral arterial disease can present in a multitude of ways in podiatric practice. How are physicians best able to assess and formulate treatment plans for these patients? Here the panelists share their experience with diagnostic...

Peripheral arterial disease can...

04/26/2021

Podiatry Today

Cover Feature

Updates in PAD Diagnosis and Treatment

08/01/2023

John N. Evans , DPM, FACFAS, DABFAS;

Peripheral arterial disease (PAD) is growing in prevalence and necessitates a lifetime of surveillance. This author discusses risk assessment, atherosclerotic vs. atherothrombotic disease, and treatment options including exercise.

Peripheral arterial disease (PAD) is growing in prevalence and necessitates a lifetime of surveillance. This author discusses risk assessment, atherosclerotic vs. atherothrombotic disease, and treatment options including exercise.

Peripheral arterial disease...

08/01/2023

Podiatry Today

Review

Peripheral Artery Disease, the Factor Xa Inhibitor Rivaroxaban, and the Role of the Podiatrist

06/08/2021

Nicholas C. Claussen , BA;

Courtney S. Leslie , PharmD;

Kenneth T. Moore , MA, MS;

John N. Evans , DPM, FACFAS, DABFAS;

This review serves to introduce the most recent data with a factor Xa inhibitor as a novel antithrombotic strategy for PAD.

This review serves to introduce the most recent data with a factor Xa inhibitor as a novel antithrombotic strategy for PAD.

This review serves to introduce...

06/08/2021

Videos

Facing the Challenges of PAD and CLI in Diabetic Foot Disease

01/25/2023

John N. Evans , DPM, FACFAS, DABFAS;

Learn more about Dr. Evans' thoughts on meeting the challenges of peripheral arterial disease head-on.

Learn more about Dr. Evans' thoughts on meeting the challenges of peripheral arterial disease head-on.

Learn more about Dr. Evans'...

01/25/2023

Podiatry Today

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Advertisement

Advertisement

Advertisement

Upcoming Events

November 6 ⁠–⁠ November 8

NEI Congress

November 7 ⁠–⁠ November 10

November 8 ⁠–⁠ November 10

WoundCon

November 8

Dermatology Week

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

See Full Calendar

Advertisement

Advertisement